We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Max Planck Institute Purchases Automation Technology from Formulatrix
News

Max Planck Institute Purchases Automation Technology from Formulatrix

Max Planck Institute Purchases Automation Technology from Formulatrix
News

Max Planck Institute Purchases Automation Technology from Formulatrix

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Max Planck Institute Purchases Automation Technology from Formulatrix"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

According to Formulatrix, the department of Biophysical chemistry has successfully deployed Rock Maker and Rock Imager for automation of protein crystallization.

Martin Kollmar, group leader of Biophysical Chemistry department at MPI said, "We were looking for a software solution that not only allows for designing and tracking of crystallization experiments, but also operates liquid handling and imaging robots.

As far as we know, Rock Maker is the only software on the market that solves this problem. In addition, Formulatrix builds an imaging robot that provides very good pictures of crystallization drops from all kinds of 96-well plates. We are very happy that Formulatrix was able to deliver a customized solution, and that we get immediate support."

Jeremy Stevenson, founder and CEO of Formulatrix stated "We are very pleased to add Max Planck to our growing list of customers, especially as a key reference site for the European market."

Formulatrix specializes in providing technology that automates the protein crystallization process, a key part of structure based drug discovery.
Advertisement